Last reviewed · How we verify
NCT07247955
Guided and Traditional Cognitive Behavioral Therapy Protocol for Resistant Panic
NA trial testing The group intervention used the sessions described in traditional form in Panic Disorder in 46 participants. Completed in 2 May 2025.
15 October 2024
Quick facts
| Lead sponsor | Universidade Federal do Rio de Janeiro |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 46 |
| Start date | 5 April 2023 |
| Primary completion | 15 October 2024 |
| Estimated completion | 2 May 2025 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- The group intervention used the sessions described in traditional form
- The group intervention used the sessions described in a self-guided format using an application
Conditions studied
- Panic Disorder — all drugs for Panic Disorder →
Sponsor
Universidade Federal do Rio de Janeiro — full company profile →
Who can join
Adults 18 to 60, any sex, with Panic Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Self-guided therapy for anxiety disorders has focused on various cognitive-behavioral treatments mediated by technologies such as web applications. This study aims to compare two groups of patients with panic disorder undergoing two clinical psychological treatment models: one traditional cognitive behavioral therapy (CBT), and the other self-guided CBT using a digital application. An application was developed in which both treatment models follow the same eight-session CBT manual. Patients are evaluated using psychological assessments at the first and eighth sessions. The study includes 46 patients divided into two groups of 23 participants each. Both groups undergo individual assessments at the beginning and end of the treatment protocol.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07247955
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Panic Disorder
Currently open trials in the same condition.
- NCT06661460 — Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders · NA · recruiting
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT07444879 — IL-33, sST2, and CRP in Panic Disorder · recruiting
- NCT07024758 — Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolesce · NA · recruiting
- NCT06942429 — Stepped Versus Stratified Care for Anxiety Disorders in Youth · NA · recruiting
Other Universidade Federal do Rio de Janeiro trials
Trials by the same sponsor.
- NCT07584564 — Application of the Concept of Proprioceptive Neuromuscular Facilitation in Trunk Control in Patients Admitted to the ICU · NA · not yet recruiting
- NCT07062497 — Clonidine in Ultrasound-guided Rectus Sheath Block for Outpatient Umbilical Hernioplasty · Phase 2, PHASE3 · recruiting
- NCT07191743 — Functional Assessment in Critically Ill Patients · recruiting
- NCT06733714 — Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in · NA · recruiting
- NCT07391943 — Self-Guided CBT Mobile App for Treatment-Resistant Panic Disorder (CBT) Cognitive Behavioral Therapy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07247955 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidade Federal do Rio de Janeiro
- Last refreshed: 25 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07247955.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing